Document is current
Any future updates will be listed below
-
Authors
Lu, Lu
Li, Huan
Yin, Hongfang
Wang, Feng
Sun, Xiaowen
Chang, Yanyun
Sheng, Yuling
Liu, Qi
Peng, Yifan
Du, Changzheng
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (32170590)
Shenzhen Science and Technology Research and Development Fund (JCYJ20220530113814033)
- License Information
-
More Information
Article History
Received: 22 December 2024
Accepted: 15 April 2025
First Online: 23 April 2025
Declarations
:
: All participants provided informed consent prior to treatment initiation, and the study protocol was approved by the ethics committee of Peking University Cancer Hospital (Resolution #: 20110225) and conformed to the ethical standards for medical research involving human subjects, as laid out in the 1964 Declaration of Helsinki and its later amendments.
: Not Applicable.
: The authors declare no competing interests.
